期刊文献+

基质金属蛋白酶-9基因多态性与新疆维吾尔族急性冠脉综合征的相关性 被引量:6

Association between matrix metalloproteinase-9 polymorphism (-1562C 〉 T/R279Q) and acute coronary syndrome in Uygur nationality of Xinjiang Autonomous Region of China
原文传递
导出
摘要 目的 探讨新疆维吾尔族人群基质金属蛋白酶-9(matrix metalloproteinase-9,MMP-9)基因多态性与急性冠脉综合征(acute coronary syndrome,ACS)的相关性.方法 采用病例对照研究,选择2006年1月至2009年12月在新疆医科大学第一附属医院心脏中心住院并行冠状动脉造影检查证实的维吾尔族急性冠脉综合征患者352例(包括不稳定型心绞痛213例、急性心肌梗死139例)和同期入院冠状动脉造影检查阴性的对照组421例.采用聚合酶链反应-限制性片段长度多态性技术对所有纳入对象的MMP-9基因-1562C>T和R279Q多态性进行分析,并结合造影情况,探讨MMP-9基因多态性与ACS发生及冠脉狭窄程度的关系.用Hardv-Weinberg平衡检验样本群体代表性;各组基因型和等位基因频率差异比较采用x2检验,并以优势比(OR)及其95%可信区间(95%CI)表示相对的风险度;综合评价各因素与ACS相关性采用多因素Logistic回归分析;以P<0.05为差异具有统计学意义.结果 MMP-9基因-1562C>T多态性位点ACS组CT+TT基因型和T等位基因频率(25.9%,14.5%)显著高于对照组(15.7%,8.4%),差异有统计学意义(P<0.01).R279Q位点ACS组和对照组RQ+QQ基因型和Q等位基因频率分别为67.0%,45.6%,64.6%,42.0%,两组比较差异无统计学意义(P>0.05).多因素Logistic回归分析显示-1562T等位基因是ACS发生的独立风险因素(P<0.05).不同冠脉病变支数亚组中CT+TT基因型和CC基因型的分布比较差异无统计学意义(P>0.05).结论 MMP-9基因1562C>T多态性与新疆维吾尔族人群ACS的发生可能相关,T等位基因可能是ACS遗传易感性的基因标记之一,-1562C>T基因多态性与ACS冠脉狭窄程度无关,R279Q基因多态性与维吾尔族人群ACS发生未见明显相关. Objective To investigate the association between matrix metalloproteinase-9 (MMP-9) gene polymorphism (-1562C 〉 T/R279Q) and acute coronary syndrome (ACS) in Uygur nationality of Xinjiang Autonomous Region of China. Methods A total of 352 patients with ACS including 213 patients with unstable angina pectoris and 139 patients with acute myocardial infarction evidenced by using coronary arteriography and 421 control subjects were recruited in this study. The MMP-9-1562C 〉 T and R279Q genotypes were detemined by using PCR-RFLP method. The relationship between the polymorphism in the MMP-9 gene and the severity of coronary arterial stenosis was analyzed. All polymorphisms were determined for confimation with Hardy-Weinberg expectations in both groups separately. Differences in distributions of genotypes and alleles between two groups were analyzed with x2 test. The association between the MMP-9 polymorphisms and the risk of ACS was estimated by odds ratio(Ors) and their 95% confidence intervals (CIs), and the comprehensive evaluation of the factors associated with ACS was determined by using multifactor logistic regression. P 〈 0. 05 was considered to be statistically significant. Results The genotype frequencies for CT + TT genotypes and T allele were 25.9 and14.5 percent in ACS subjects and 15.7 and 8.4 percent in control subjects, respectively. The genotype frequencies were different significantly between the two groups (x2 = 12.26,P 〈 0.01;x2 = 14.15,P 〈 0.01, respectively). No relationship between R279Q polymorphism and ACS was found in this study ( P 〉 0.05). The multifactor logistic regression analysis showed that the T allele carrier (CT + TT) significantly increased the risk of ACS compared with the CC genotype ( OR = 1.791,95 % CI: 1. 088 - 2.951, P = 0.022) after adjustment for tradition risk factors. The frequencies for CT + TT and CC genotypes of the -1562C 〉 T polymorphism were not statistically different among ACS patients with one, two and three or more significantly diseased vessels ( x2 = 1.15, P = 0.56). Conclusions The findings suggest that the polymorphism in MMP-9 gene promoter (-1562C 〉 T) is associated with the susceptibility to the ACS. The T allele might be an independent risk factor for the ACS. But the -1562C 〉 T polymorphism may not be useful as a predictor of the severity of coronary arterial stenosis. The R279Q polymorphism of MMP-9 gene was not significantly associated with ACS in this studied population.
出处 《中华急诊医学杂志》 CAS CSCD 北大核心 2010年第11期1146-1150,共5页 Chinese Journal of Emergency Medicine
基金 新疆维吾尔自治区重大专项课题(200733146-3)
关键词 基质金属蛋白酶-9 急性冠脉综合征 维吾尔族 基因多态性 Matrix metalloproteinase-9 Acute coronary syndrome Uygur population Gene polymorphism
  • 相关文献

参考文献14

  • 1Newby AC.Dual role of matrix metalloproteinases(matrixins) in intimal thickening and atherosclerotic plaque rupture[J].Physiol Rev,2005,85(1):1-31.
  • 2Johnson JL,Fritsche-Danielson R,Behrendt M,et al.Effect of broadspectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability[J].Cardiovasc Res,2006,71(3):586-595.
  • 3何春燕,周新,熊鹰,王玲,吴洁,喻红.急性冠脉综合征患者MMP-3基因启动子5A/6A的多态性分析[J].中华急诊医学杂志,2004,13(11):748-750. 被引量:4
  • 4Fan JH,Gao LB,Pan KM,et al.Association between IRF-5 polymorphisms and acute coronary syndrome[J].DNA Cell Biol,2010,29(1):19-23.
  • 5徐耕,金国栋,傅国胜,马骥,施育平,单江.急性冠状动脉综合征患者C-反应蛋白及其1059G/C基因多态性的研究[J].中华急诊医学杂志,2003,12(4):223-226. 被引量:54
  • 6Nurkic J,Ljuca F,Nurkic M,et al.Biomarkers of plaque instability in acute coronary syndrome patients[J].Med Arh,2010,64(2):103-106.
  • 7Kim JS,Park HY,Kwon JH,et al.The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina[J].Yonsei Med J,2002,43(4):473-481.
  • 8Morgan AR,Zhang B,Tapper W,et al.Hapbtypic analysis of the MMP-9 gene in relation to coronary artery disease[J].J Mol Med,2003,81 (5):321-326.
  • 9Zhi H,Wang H,Ren L,et al.Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population[J].Mol Biol Rep,2010,37(1):13-20.
  • 10Cho HJ,Chae IH,Park KW,et al.Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention[J].J Hum Genet,2002,47(2):88-91.

二级参考文献13

  • 1Ye S, Eriksson P, Hamsten A, et al. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin -1 promoter which results in reduced gene expression. J Biol Chem, 1996, 271: 13055-13060.
  • 2Pollanen PJ, Lehtimaki T, Ilveskoski E, et al. Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study. Atherosclerosis,2002, 164: 329-335.
  • 3Beyzade S, Zhang S, Wong Y, et al. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. Journal of the American College of Cardiology, 2003, 41: 2130-2137.
  • 4Kim JS, Park HY, Kwon JH, et al. The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina. Yonsei Medical Journal, 2002, 43: 473-481.
  • 5Terashima M, Akita H, Kanazawa K, et al. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction.Circulation, 1999, 99: 2717-2719.
  • 6Ye S. Rapid genotype analysis of the stromelysin gene 5A/6A polymorphism. Atherosclerosis, 2000, 151: 587-589.
  • 7Cao H;Hegele RA.Human C-reactive (CRP)1059G/C polymorphism[J],2000(55).
  • 8Ferranit SD;Rifai N.C-reactive protein and cardiovascular disease:a review of risk prediction and intervention[J],2002(1/2).
  • 9Mueller C;Buettner HJ;Hodgson JM.Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients[J],2002(12).
  • 10Zee R;Ridker PM.Polymorphsim in the human C-reactive protein(CRP)gene,plasma concentrations of CPR,and the risk of future arterial thrombosis[J],2002.

共引文献55

同被引文献74

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部